Ziipman Herbal Capsules are a natural supplement formulated for men’s health, particularly targeting waist pain and sexual weakness. The active ingredient is Paullinia pinnata, a plant traditionally used for its medicinal properties.
Price: ₵32.50
Description:
Ziipman Herbal Capsules are a natural supplement formulated for men’s health, particularly targeting waist pain and sexual weakness. The active ingredient is Paullinia pinnata, a plant traditionally used for its medicinal properties.
Prescription:
Ziipman Herbal Capsules are available over-the-counter and do not require a prescription.
Therapeutic Category:
Herbal supplement for male vitality and sexual health.
Active Ingredients/Composition:
Each capsule contains extracts from Paullinia pinnata.
Vitamins:
The specific vitamin content is not detailed in the available information.
Minerals:
The specific mineral content is not detailed in the available information.
Variant:
Ziipman Herbal Capsules are available in a 30-capsule pack.
Consume Type:
Oral capsules.
Directions/Usage:
The recommended dosage is two capsules taken twice daily after meals. It’s important to follow the manufacturer’s instructions or consult a healthcare professional for personalized advice.
Common Side Effects:
There are no reported side effects associated with Ziipman Herbal Capsules. However, if you experience any adverse reactions, discontinue use and consult a healthcare professional.
Package Type:
Ziipman Herbal Capsules are packaged in bottles containing 30 capsules.
Storage Advice:
Store in a cool, dry place away from direct sunlight. Keep out of reach of children.
Safety Advice:
Product Substitutes:
Other herbal supplements aimed at male vitality and sexual health are available. It’s advisable to consult with a healthcare professional to determine the most appropriate option for your needs.
Manufacturer/Marketer:
Ziipman Herbal Capsules are produced by Solak Biochemist.
Country of Origin: Ghana.
Do you have any questions? Do not hesitate to contact us.
Reviews
There are no reviews yet.